Philip Johnson

Professor Johnson qualified in medicine at the University of Manchester and subsequently held posts as Senior House Officer at four major London Postgraduate Centres, including the Royal Marsden Hospital, before moving to the Liver Unit at King's College Hospital, London. Here he gained initial training in hepatology, and an introduction to clinical and laboratory research in the field of liver and pancreatic cancer.

After a two year appointment at Manchester Royal Infirmary as Senior Registrar in General Medicine and Gastroenterology he returned to the Liver Unit at King's College Hospital, London (now The Institute of Liver Studies), as Senior Lecturer and Assistant Director, in charge of the newly built extension to the Unit, the Sheikh Zaid Centre.

From London he moved to The Chinese University of Hong Kong where he was Professor of Clinical Oncology and Head of Department. He commissioned a new Cancer Centre (the Sir Y.K. Pao Centre for Cancer) involving over 300 researchers and built up the Comprehensive Clinical Trials Unit.

Professor Johnson returned to the UK in 2002 and holds the Chair of Oncology and Translational Research at the School of Cancer Sciences, University of Birmingham. He is also Director of the Cancer Research UK Clinical Trials Unit, one of the largest of its type in the United Kingdom.

His main clinical interest is in hepatobiliary cancer and biomarker discovery in the setting of clinical trials. He has over 400 publications.including original papers, textbook chapters and reviews.

Philip Johnson